Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Principia Biopharma Inc. (PRNB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/06/2020 |
8-K
| Quarterly results |
| 05/06/2020 |
8-K
| Quarterly results |
| 03/10/2020 |
8-K
| Quarterly results |
| 11/05/2019 |
8-K
| Quarterly results |
| 08/08/2019 |
8-K
| Quarterly results |
| 05/07/2019 |
8-K
| Quarterly results|
Docs:
|
"Principia Biopharma Inc. Condensed Consolidated Statements of Operations Three Months Ended March 31, 2019 2018 Revenue $ 5,160 $ 11,449 Operating expenses: Research and development 15,523 8,761 General and administrative 4,508 2,156 Total operating expenses 20,031 10,917 Income from operations 532 Other income , net 1 Interest income 1,183 115 Net income $ $ 310 Net income attributable to common stockholders $ $ — Net income per share attributable to common stockholders Basic $ $ — Diluted $ $ — Weighted-average shares used to calculate net income per share attributable to common stockholders Basic 23,866,066 630,359 Diluted 23,866,066 1,170,670 Principia Biopharma Inc." |
|
| 03/19/2019 |
8-K
| Quarterly results |
| 11/06/2018 |
8-K
| Quarterly results |
|
|